Industry Leaders

  1. 6 Tips For Contracting Or Seeking Funding From The Federal Government

    With the right preparation and investments, entering the federal government market can lead to considerable growth and visibility for your company. Consider the following tips for increased chances of success.

  2. The Great Regulatory Catch-Up: Shortcuts To Compliance For Medical Devices Manufacturers

    The medical device market is about to succumb to a raft of substantial international regulatory changes, starting with Europe’s MDR in May 2020, as public pressure and industry authorities call for greater accountability for patient safety.

  3. A Different Path To An IPO

    Typically, there are two paths biotechs take when going public — seeking VC funding or raising capital via a reverse merger. However, INmune Bio chose a third path.

  4. Data Analytics Are Unlocking Valuable Cold-Chain Insights

    Much like in many other areas of the drug development continuum, the focus now in the cold chain is on data and how it can be unlocked and analyzed in real time to save money, time, and resources — while also better ensuring patient safety.

  5. Greater Rigor Is Needed To Enable Real-World Evidence To Reach Its Full Potential

    As the industry’s appetite for creating and using data-driven insights to improve clinical outcomes continues to grow, so does the need to integrate and validate disparate data sources. Efforts to impose greater consistency and rigor should be welcomed by all.

  6. AI In Life Sciences — Seeing Past The Hype

    Life science leaders must balance their need to apply AI technologies to improve patient care, and bottom lines — without getting caught-up in the AI hype machine.

  7. Pitching Investors: It’s About You, Not The Slide Deck

    Let’s face it … pitching potential investors is a remarkable opportunity. It could be your one shot at getting your idea or company off the ground, so you better be appealing, tantalizing, and even provocative.

  8. Beyond Capital and Mentoring: Paving The Way For Female Entrepreneurs

    Women who are starting life sciences companies often do not have access to a network of mentors and advisors, whose strong advocacy establishes instant credibility and opens the doors to investors.

  9. Why Soft Skills Are The Key To Better Science And Collaborations

    Here are some examples of why “soft skills,” such as those related to relationship building, leadership, and communication, are essential to today’s pharma and biotech leaders.

  10. As Pediatric Rare Disease Patients Grow Up, Can We Keep Pace?

    Companies frequently talk about being patient-centric. But what I don’t hear discussed as often is the role of the patient after a drug is approved. And I am convinced it is equally important. Why? Because patients are not static; they grow and change over time.